top of page


  • Valuate Health Consultancy

Market Access POV: ICER and Specialty Drug Coverage

Market Access POV: ICER and Specialty Drug Coverage

The Institute for Clinical and Economic Review (ICER) is an influential organization in the pharmaceutical industry, yet market access professionals are often uncertain of its mission. ICER helps provide recommendations for the price and coverage of medical treatments, including specialty drugs. By engaging with ICER and considering its assessments, manufacturers can help ensure that their drugs are evaluated fairly and that patients can access the most effective and affordable treatments.

Valuate Health Consultancy has created a new Point of View (POV) to help market access teams better understand and leverage the work performed by ICER. Read the POV here.

If your organization needs help optimizing your commercialization and value strategy, contact our team today.

Archbow Consulting and Valuate Health Consultancy are sister companies under the Value and Access division of Omnicom Health Group. Learn more about our united organizations here.

For additional insights on this topic, you may also enjoy the following:

Related Blog Posts:

Related Case Studies:


Archbow Consulting helps pharmaceutical and biotech companies in the USA and Europe design, build, and optimize product distribution and patient access strategies. Archbow was founded by industry veterans to meet a need in the marketplace for consulting options that offer diverse real-world experience, are able to leverage deep connections across the industry, and can also provide actionable strategic guidance. We invite you to learn more about our team, services, and clients’ success, and connect with us via email, LinkedIn, Twitter or subscribing to this blog which you can do below.


bottom of page